cancer

: ncrm : : nichi-in centre for regenerative medicine(ncrm), chennai, india an indo-japan venture on stem cell therapeutics tissue engineering,feat,fujio-eiji academic terrain, stem cells phd, tprm courses
nichiin*centreforregenerativemedicine(ncrm)institutecarryingoutresearch,clinicalapplicationsprocoldevelopmentinregenerativemedicinestemcellsindiasfirstinstituteforregenerativemedicine


webmd - better information. better health.
theleadingsourcefortrustworthyandtimelyhealthandmedicalnewsandinion.providingcrediblehealthinion,supportivecommunity,andeducationalservicesbyblendingawardwinningexpertisein,communityservices,expertcommentary,andmedicalrevw.


cancer foundation for research | v foundation
thevfoundationforcancerresearchwasfoundedbylegendarycoachjimvalvanowithonegoalinmind:toachievevictoryovercancer.


beigene | cancer has no borders. neither do we.
beigeneisaglobal,science-drivenoncologycompanyfocusedondevelopinginnovativeandaffordablemedicinestoimprovetreatmentoutcomesandaccessforpatientsworldwide.


api manufacturer & supplier company china, intermediate manufacturer & supplier china : tianyuanpharm
tianyuanpharmaceuticalco.,ltdisamanufacturerspecializingintargetedanticancerdrugresearchandisdevotedtoresearching,manufacturingandmarketingmedicalrawmaterials.


leukemia & lymphoma society | donate today!
llsisthegloballeaderinthefightagainstbloodcancerdedicatedtofundingresearch,findingcuresandensuringaccesstotreatmentsforpatients.


5 for the fight // donate $5 to defeat cancer
100%ofthedonationsfundbold,groundbreakingcancerresearchandthewomenandmenbraveenoughtopursueacure.


安泰康生物|anticancer
安泰康是美国anticancer.inc在华合资企业,以加州大学全球首创并经历多年研究验证的hdra(histoculturedrugresponseassay,肿瘤组织体外培养药物敏感性检测)技术和可视化pdox(patientderivedorthotopicxenograft,患者来源原位移植瘤模型、转移瘤模型)技术为依托,一方面为肿瘤临床提供可评价率高、保真度高、临床一致性好的抗癌药物敏感性检测产品及技术服务


โรงพยาบาลมะเร็งกรุงเทพ วัฒโนสถ - 360° cancer care | wattanosoth cancer hospital


amoydx
avisionarydiagnosticcompanydedicatedtotransformingthelandscapeofcancercare.breakingbarrierstoprecisiononcologyreflectsourcommitmenttorevolutionizingcancerdiagnosisandtreatment.
